CAPTRUST Financial Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History

CAPTRUST Financial Advisors’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$184K	Buy	+10,854	New	+$173K	﹤0.01%	2907
2022 Q3	–	Sell	-1,700	Closed	-$17K	–	2219
2022 Q2	$17K	Sell	1,700 -500	-23%	-$5.59K	﹤0.01%	3446
2022 Q1	$27K	Hold	2,200	–	–	﹤0.01%	3211
2021 Q4	$50K	Hold	2,200	–	–	﹤0.01%	2662
2021 Q3	$49K	Hold	2,200	–	–	﹤0.01%	2586
2021 Q2	$29K	Sell	2,200 -2,000	-48%	-$25.5K	﹤0.01%	2854
2021 Q1	$55K	Buy	4,200 +2,000	+91%	+$29K	﹤0.01%	2376
2020 Q4	$30K	Hold	2,200	–	–	﹤0.01%	2063
2020 Q3	$32K	Hold	2,200	–	–	﹤0.01%	1776
2020 Q2	$35K	Buy	+2,200	New	+$35.2K	﹤0.01%	1751
2019 Q4	–	Sell	-2,200	Closed	-$12K	–	1062
2019 Q3	$12K	Hold	2,200	–	–	﹤0.01%	1436
2019 Q2	$14K	Hold	2,200	–	–	﹤0.01%	1389
2019 Q1	$14K	Buy	+2,200	New	+$14.6K	﹤0.01%	1285

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's AUPH Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 10,854 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #2907 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in AUPH as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in AUPH in Q1 2019 and has held it in 13 quarters since. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

CAPTRUST Financial Advisors held 10,854 shares of Aurinia Pharmaceuticals worth $184K as of Q2 2026.
Aurinia Pharmaceuticals was a new CAPTRUST Financial Advisors position in Q2 2026.
Aurinia Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2907 holding.
CAPTRUST Financial Advisors first reported a position in Aurinia Pharmaceuticals in Q1 2019 and has held it in 13 quarters since.
283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.